The vagus nerve can become inflamed through several distinct mechanisms — viral invasion, autoimmune attack, surgical trauma, compression, and metabolic damage. This is different from the vagus nerve’s well-known role in controlling systemic inflammation through the cholinergic anti-inflammatory pathway. When the vagus nerve itself is the target of inflammation, the clinical presentation depends on which branches are affected and whether the inflammatory process is acute or chronic. Understanding the specific causes of vagal inflammation guides both diagnosis and treatment, because an autoimmune vagal neuropathy requires a fundamentally different approach than a post-surgical neuritis or a viral ganglionopathy.
Viral and Infectious Vagal Neuritis
Viral infection is one of the most common causes of acute vagus nerve inflammation. Herpes family viruses — particularly varicella-zoster virus (VZV, the cause of shingles) and herpes simplex virus — have a well-documented tropism for neural tissue. These viruses establish latent infection in sensory ganglia, including the nodose and jugular ganglia of the vagus nerve. Reactivation produces ganglionic inflammation, demyelination, and axonal damage along the affected vagal branches. When VZV reactivates in the vagal ganglia, it can cause the Ramsay Hunt variant that involves the auricular branch (producing ear pain and vesicles in the ear canal) along with vocal cord paralysis from recurrent laryngeal nerve inflammation.
Epstein-Barr virus (EBV) and cytomegalovirus (CMV) have both been associated with cranial neuritis that can involve the vagus. Post-infectious vagal neuropathy — where vagal dysfunction develops days to weeks after a respiratory or gastrointestinal infection — is increasingly recognised as a clinical entity. The mechanism is thought to involve molecular mimicry or bystander immune activation: the immune response mounted against the pathogen cross-reacts with vagal nerve antigens or produces local inflammation that damages the nerve. This is the same mechanism that drives Guillain-Barre syndrome (GBS), in which vagal involvement produces autonomic instability (tachycardia, blood pressure fluctuations, gastroparesis) alongside the more visible limb weakness.
COVID-19 introduced a new dimension to viral vagal neuritis. SARS-CoV-2 can enter vagal neurons through ACE2 receptors present on nodose ganglion cells, and post-COVID autonomic dysfunction — manifesting as tachycardia, gastroparesis, voice changes, and orthostatic intolerance — has been reported in large cohort studies. Whether this represents direct viral neurotropism, immune-mediated nerve damage, or microglial activation in the brainstem vagal nuclei remains under investigation, but the clinical picture of post-COVID vagal dysfunction is well documented and can persist for months to years.
Autoimmune Vagal Neuropathy
The immune system can target the vagus nerve directly in several autoimmune conditions. Autoimmune autonomic ganglionopathy (AAG) is the most specific: patients develop antibodies against the ganglionic nicotinic acetylcholine receptor (gAChR), which is present in autonomic ganglia including the vagal ganglia. These antibodies disrupt synaptic transmission in the ganglia, producing widespread autonomic failure — orthostatic hypotension, anhidrosis, gastroparesis, constipation, urinary retention, and fixed heart rate. Vagal involvement is prominent because the vagus carries the majority of the body’s parasympathetic output.
Sarcoidosis produces granulomatous inflammation that can infiltrate cranial nerves, including the vagus. Neurosarcoidosis affecting the vagus presents with vocal cord paralysis, dysphagia, or unexplained gastroparesis, and the granulomatous infiltration can be visible on high-resolution MRI of the vagus nerve or its brainstem nuclei. Sjogren syndrome, lupus, and other systemic autoimmune conditions can produce a small-fibre neuropathy that includes the small unmyelinated vagal afferents, manifesting as autonomic dysfunction (reduced HRV, gastroparesis, dry mouth from reduced parasympathetic secretomotor output) that is often under-recognised.
Paraneoplastic autonomic neuropathy — where antibodies produced against a tumour (typically small-cell lung cancer) cross-react with neural tissue — can target the vagal ganglia and produce severe autonomic failure including gastroparesis and cardiac dysautonomia. Anti-Hu (ANNA-1) antibodies are the most commonly associated, and the autonomic symptoms often precede the discovery of the underlying malignancy.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Surgical and Traumatic Vagal Injury
Surgical injury is the most common cause of isolated vagal branch damage. The recurrent laryngeal nerve — the vagal branch that controls the vocal folds — is at risk during thyroid surgery (0.5 to 2 percent injury rate for experienced surgeons), parathyroid surgery, anterior cervical spine surgery, carotid endarterectomy, and cardiothoracic procedures. The injury produces inflammation at the surgical site, followed by either recovery (if the nerve is intact but stretched or compressed) or permanent paralysis (if the nerve is transected or severely damaged). Intraoperative nerve monitoring has reduced but not eliminated this risk.
The abdominal vagal trunks can be damaged during fundoplication (anti-reflux surgery), hiatal hernia repair, bariatric surgery, and oesophagectomy. Post-surgical vagal gastroparesis — delayed stomach emptying caused by loss of vagal motor input to the gastric musculature — is a recognised complication of these procedures and can be permanent. The vagal trunks are thin, translucent structures that lie on the oesophageal surface at the diaphragmatic hiatus, making them vulnerable to traction, cautery, or inadvertent transection.
Blunt or penetrating neck trauma can damage the cervical vagus directly, producing a combination of laryngeal, pharyngeal, and cardiac vagal dysfunction. Whiplash injuries have been proposed as a cause of vagal dysfunction (producing post-traumatic gastroparesis or tachycardia), though the evidence for this mechanism is limited to case reports and the causal relationship remains debated.
Metabolic and Degenerative Causes
Diabetic autonomic neuropathy is the most common cause of chronic, progressive vagal damage. Hyperglycaemia produces oxidative stress, advanced glycation end-product accumulation, and microvascular ischaemia that damages small nerve fibres, including the vagal afferents and efferents. The vagal cardiac fibres are often affected first — producing reduced HRV and resting tachycardia — followed by gastrointestinal vagal damage (gastroparesis, constipation, loss of the migrating motor complex). Diabetic vagal neuropathy is dose-dependent: the longer the duration of poorly controlled diabetes and the higher the cumulative glycaemic exposure, the more severe the vagal damage.
In Parkinson’s disease, alpha-synuclein pathology affects the dorsal motor nucleus of the vagus nerve in the brainstem — the origin of vagal efferent fibres to the gut, heart, and lungs — early in the disease course, often years before motor symptoms appear. The Braak staging hypothesis proposes that alpha-synuclein pathology may originate in the gut and travel retrogradely up the vagus nerve to reach the brainstem, making the vagus nerve a potential conduit for the disease’s spread. Epidemiological studies showing that truncal vagotomy (surgical cutting of the vagus) is associated with a reduced risk of developing Parkinson’s disease provide indirect support for this hypothesis.
Chronic alcohol use produces a toxic neuropathy that can include the vagus nerve, manifesting as reduced cardiac vagal tone, gastroparesis, and autonomic instability. Nutritional deficiencies — particularly B1 (thiamine), B12, and folate — contribute to this neuropathy and can cause vagal dysfunction independently of alcohol.
Compression and Mechanical Causes
Tumours of the skull base, neck, or mediastinum can compress the vagus nerve and produce inflammation from chronic pressure. Glomus jugulare tumours (paragangliomas at the jugular foramen) compress the vagus as it exits the skull, producing progressive hoarseness, dysphagia, and shoulder weakness (the jugular foramen also contains cranial nerves IX and XI). Mediastinal lymphadenopathy from lymphoma or sarcoidosis can compress the recurrent laryngeal nerve where it loops under the aortic arch (left side) or subclavian artery (right side), producing isolated vocal cord paralysis.
The vagus nerve at the diaphragmatic hiatus can be compressed or stretched by a hiatal hernia — the protrusion of the stomach through the diaphragmatic opening. This mechanical distortion may contribute to the autonomic symptoms (palpitations, breathlessness, early satiety) reported by some patients with large hiatal hernias, though the precise mechanism and its contribution relative to gastric distension and acid reflux remain debated.
Diagnosis and Management Principles
Identifying the cause of vagal inflammation determines the treatment approach. Viral neuritis may respond to antiviral therapy (acyclovir for VZV reactivation) and corticosteroids to reduce inflammatory oedema. Autoimmune vagal neuropathies require immunomodulatory treatment — intravenous immunoglobulin (IVIG), plasma exchange, or corticosteroids for GBS and AAG; disease-specific immunosuppression for sarcoidosis and lupus. Surgical vagal injury management depends on severity: observation and speech therapy for mild recurrent laryngeal nerve injuries (most recover within 6 to 12 months), with surgical procedures (thyroplasty, vocal fold injection) for permanent paralysis. Diabetic vagal neuropathy requires optimised glycaemic control to slow progression, along with symptomatic management of gastroparesis and cardiac autonomic dysfunction.
For all causes, assessment should include cardiac autonomic reflex testing (to quantify vagal cardiac function), laryngoscopy (if voice or swallowing symptoms are present), gastric emptying studies (if gastroparesis is suspected), and serological testing for autoimmune markers (gAChR antibodies, anti-Hu, inflammatory markers) when an autoimmune cause is considered. High-resolution ultrasound of the cervical vagus nerve is emerging as a non-invasive tool that can identify nerve swelling (suggesting inflammation) or atrophy (suggesting chronic damage).
The vagus nerve is vulnerable to inflammation from multiple directions — viral, immune, surgical, metabolic, and mechanical — and the symptoms depend entirely on which branches are damaged. Understanding these mechanisms is the first step toward targeted treatment. Get My Vagus Nerve & Me eBook for a complete guide to vagal anatomy, dysfunction, and the evidence-based approaches to protecting and restoring vagal health.
